Keyphrases
Tumor-infiltrating Lymphocytes
100%
Tumor-specific T Cells
100%
Adoptive Cell Therapy
100%
Metastatic Soft Tissue Sarcoma
100%
LTX-315
100%
Systemic Immune Response
33%
Clinical Response
16%
Progressive Disease
16%
In Silico
16%
Disease Progression
16%
Autoreactive T Cells
16%
Local Immune Response
16%
Treatment Protocol
16%
Clinical Activity
16%
Stable Disease
16%
T Cell Clone
16%
T-cell Reactivity
16%
Sarcoma
16%
Heavily Pretreated Patients
16%
Neoantigen
16%
Intratumoral Injection
16%
Oncolytic Peptide
16%
Medicine and Dentistry
T Cell
100%
Soft Tissue Sarcoma
100%
Tumor Infiltrating Lymphocyte
100%
Specific Tumor
100%
Cell Therapy
100%
Disease
28%
Immune Response
28%
Neoplasm
14%
In Vitro
14%
Progressive Disease
14%
In Silico
14%
Disease Exacerbation
14%
Sarcoma
14%
Intratumoral Drug Administration
14%
Immunology and Microbiology
T Cell
100%
Tumor-Infiltrating Lymphocytes
100%
Soft Tissue
100%
Immune Response
28%
Computer Model
14%
Cell Clone
14%
Neoantigen
14%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Tumor-Infiltrating Lymphocytes
100%
Immune Response
28%
Computer Model
14%
Cell Clone
14%